Internal Medicine, Endocrinology, Diabetes, & Metabolism · Summerville, SC
NPI
1811123300
Since 2009
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1101 Old Trolley Rd, Ste. 300
Summerville, SC, 29485
Phone (843) 376-2670
Groups this clinician bills Medicare through
Medicare paid, 2024
$458K
12,260 services
Medicare patients, 2024
1,002
Average age 71
Drug cost, 2024
$4.4M
1,462 prescriptions
Company payments, 2025
$5,260
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph W Mathews was code J0897 (injection, denosumab, 1 mg), 5,940 times for 64 patients. In total Joseph W Mathews billed 12,260 services in 30 codes, and Medicare paid $458K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,940 | 64 | $20.56 | $122K |
| 99214 Office E&M - Established | Office | 1,961 | 823 | $81.58 | $160K |
| 36415 Venipuncture Blood Collection | Office | 1,000 | 448 | $8.63 | $8,634 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 986 | 661 | $12.27 | $12K |
| 99215 Office E&M - Established | Office | 570 | 301 | $120.88 | $69K |
| 95251 Test - Miscellaneous | Office | 477 | 120 | $24.35 | $12K |
| 99454 E&M - Miscellaneous | Office | 309 | 46 | $33.20 | $10K |
| 99442 Telephone Services | Office | 240 | 177 | $63.96 | $15K |
| 76536 Ultrasound - Nonspecific | Office | 144 | 142 | $72.81 | $10K |
| 99205 Office E&M - New | Office | 111 | 111 | $145.85 | $16K |
| 96372 Injection Administration | Office | 111 | 66 | $10.48 | $1,163 |
| 99441 Telephone Services | Office | 106 | 78 | $39.50 | $4,187 |
| 10005 Other Organ Systems | Office | 50 | 48 | $92.86 | $4,643 |
| 99443 Telephone Services | Office | 48 | 31 | $94.74 | $4,547 |
| 99457 E&M - Miscellaneous | Office | 47 | 25 | $36.28 | $1,705 |
By year: 2022 $113K for 4,748 services; 2023 $328K for 8,424 services; 2024 $458K for 12,260 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,000 | 448 | $8.63 | $8,634 |
| 83036 Blood Count | 23 | 21 | $8.40 | $193 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph W Mathews prescribed most often to Medicare patients was Levothyroxine Sodium, with 209 prescriptions and refills. In total Joseph W Mathews wrote 1,462 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 209 | 530 | 74 | $1,534 |
| Liothyronine Sodium Generic | 142 | 388 | 60 | $8,698 |
| Korlym Mifepristone | 73 | 73 | 12 | $3.6M |
| Synthroid Levothyroxine Sodium | 72 | 190 | 22 | $6,339 |
| Jardiance Empagliflozin | 52 | 118 | 21 | $68K |
| Metformin Hcl Er Metformin Hcl | 49 | 123 | 29 | $504 |
| Farxiga Dapagliflozin Propanediol | 48 | 80 | 16 | $42K |
| Dexamethasone Generic | 46 | 46 | 46 | $30.82 |
| Mounjaro Tirzepatide | 42 | 55 | 18 | $58K |
| Trulicity Dulaglutide | 42 | 56 | 14 | $51K |
| Rosuvastatin Calcium Generic | 33 | 81 | 13 | $486 |
| Pioglitazone Hcl Generic | 32 | 84 | 12 | $584 |
| Ozempic Semaglutide | 31 | 60 | 12 | $54K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 31 | 72 | 13 | $3,154 |
| Methimazole Generic | 27 | 79 | 17 | $288 |
Brand drugs: 659 claims; generic drugs: 694 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph W Mathews $5,260 ($5,260 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $2,976.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 10 | $2,976 |
| Insulet Corporation PODD | 14 | $500 |
| Amgen Inc. AMGN | 7 | $272 |
| Corcept Therapeutics CORT | 17 | $227 |
| Xeris Pharmaceuticals, Inc. | 9 | $178 |
| Astellas Pharma US Inc 4503.T | 8 | $169 |
| Medtronic, Inc. MDT | 8 | $155 |
| Beta Bionics, Inc. BBNX | 6 | $120 |
| Abbott Laboratories ABT | 4 | $96.43 |
| Dexcom, Inc. DXCM | 2 | $83.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.